Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists

H.L. Heng; C.F. Chee; S.P. Chin; Y. Ouyang; H. Wang; M.J.C. Buckle; D.R. Herr; I.C. Paterson; S.W. Doughty; N. Abd Rahman; L.Y. Chung

doi:10.1039/c7md00629b

Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists

H.L. Heng
, C.F. Chee
, S.P. Chin
, Y. Ouyang
, H. Wang
, M.J.C. Buckle
, D.R. Herr
, I.C. Paterson
, S.W. Doughty
, N. Abd Rahman
, L.Y. Chung

Penang Medical College

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	576-582
Number of pages	7
Journal	MedChemComm
Volume	9
Issue number	3
DOIs	https://doi.org/10.1039/c7md00629b
Publication status	Published - 2018
Externally published	Yes

Access to Document

10.1039/c7md00629b

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044340536&doi=10.1039%2fc7md00629b&partnerID=40&md5=ea133d53ad3b8483112b96aefe672261

Cite this

@article{176d37a85a7541bc962f05622c2c368a,

title = "Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists",

author = "H.L. Heng and C.F. Chee and S.P. Chin and Y. Ouyang and H. Wang and M.J.C. Buckle and D.R. Herr and I.C. Paterson and S.W. Doughty and \{Abd Rahman\}, N. and L.Y. Chung",

note = "Export Date: 07 November 2023; Cited By: 11",

year = "2018",

doi = "10.1039/c7md00629b",

language = "English",

volume = "9",

pages = "576--582",

journal = "MedChemComm",

number = "3",

}

TY - JOUR

T1 - Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists

AU - Heng, H.L.

AU - Chee, C.F.

AU - Chin, S.P.

AU - Ouyang, Y.

AU - Wang, H.

AU - Buckle, M.J.C.

AU - Herr, D.R.

AU - Paterson, I.C.

AU - Doughty, S.W.

AU - Abd Rahman, N.

AU - Chung, L.Y.

N1 - Export Date: 07 November 2023; Cited By: 11

PY - 2018

Y1 - 2018

U2 - 10.1039/c7md00629b

DO - 10.1039/c7md00629b

M3 - Article

VL - 9

SP - 576

EP - 582

JO - MedChemComm

JF - MedChemComm

IS - 3

ER -